Previous close | 1.6500 |
Open | 1.6500 |
Bid | 1.6600 x 400 |
Ask | 1.7000 x 200 |
Day's range | 1.6400 - 1.6800 |
52-week range | 1.1750 - 9.7200 |
Volume | |
Avg. volume | 550,142 |
Market cap | 86.168M |
Beta (5Y monthly) | 1.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Strategic Focus on Rezatapopt Advances as Company Extends Cash Runway
The heavy selling pressure might have exhausted for PMV Pharmaceuticals, Inc. (PMVP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
The average of price targets set by Wall Street analysts indicates a potential upside of 239.3% in PMV Pharmaceuticals, Inc. (PMVP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.